Journal for ImmunoTherapy of Cancer (Nov 2023)

604 Clinical and molecular findings from a randomized phase II study of epigenetic priming with azacitidine and entinostat followed by nivolumab in previously treated metastatic non-small cell lung cancer

  • James Herman,
  • Chen Hu,
  • James White,
  • Patrick Forde,
  • Julie Brahmer,
  • Victor Velculescu,
  • Valsamo Anagnostou,
  • Joanne Riemer,
  • Stephen Baylin,
  • Christine Hann,
  • Jorge Nieva,
  • Margaret Fitzpatrick,
  • David Ettinger,
  • Benjamin Levy,
  • Christopher Cherry,
  • Archana Balan,
  • Noushin Niknafs,
  • Hua-Ling Tsai,
  • Kristen A Marrone,
  • Blair V Landon,
  • Michael J Topper,
  • Ronan Kelly

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.0604
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.